×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

AvroBio Inc. (AVRO) NASDAQ

$1.48 (0.03) (-1.67%)

Market Cap: $67.34M

As of 06/13/24 03:56 PM EDT. Market closed.

(AVRO)

AvroBio Inc. (AVRO)
NASDAQ

$1.48
(0.03) (-1.67%)

Market Cap: $67.34M

As of 06/13/24 03:56 PM EDT. Market closed.

Add to Portfolio

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$462,267
CEO Compensation (Total)
$2.87M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
95
CEO Compensation (Base)
$462,267
CEO Compensation (Total)
$2.87M
Address
.
PRICE CHART FOR AVROBIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.50
Previous Close
$1.50
Days Range
$1.49 - $1.51
52 week range
$0.88 - $1.65
Volume
56,730
Avg. Volume (30 days)
260,881
Market Cap
$67.34M
Dividend Yield
-
P/E
-
Shares Outstanding
44,893,750
Open
$1.50
Previous Close
$1.50
Days Range
$1.49 - $1.51
52 week range
$0.88 - $1.65
Volume
56,730
Avg. Volume (30 days)
260,881
Market Cap
$67.34M
Dividend Yield
-
P/E
-
Shares Outstanding
44,893,750
FINANCIAL STATEMENTS FOR AVROBIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AVROBIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Leonard Braden Michael10% OwnerMay 14, 2024 Buy$1.30296,882385,9474,768,262May 15, 2024, 11:21 AM
Leonard Braden Michael10% OwnerMay 13, 2024 Buy$1.25469,753585,5464,471,380May 15, 2024, 11:21 AM
Golipour AzadehChief Technology OfficerFeb 05, 2024 Option Exercise$1.2012,23214,69855,872Feb 05, 2024, 08:01 PM
Ridha EssraChief Medical OfficerFeb 05, 2024 Option Exercise$1.2016,95320,35415,881Feb 05, 2024, 07:59 PM
Ostrowski ErikInterim CEO, President and CFOFeb 05, 2024 Option Exercise$1.2013,09915,74529,285Feb 05, 2024, 07:57 PM
Avruch StevenChief Legal OfficerFeb 05, 2024 Option Exercise$1.2010,81212,99622,022Feb 05, 2024, 07:56 PM
Golipour AzadehChief Technology OfficerJun 12, 2023 Option Exercise$1.195,5746,63530,881Jun 13, 2023, 04:32 PM
MACKAY GEOFFREYPresident & CEOJan 24, 2023 Option Exercise$0.9145,99941,859188,012Jan 26, 2023, 05:30 PM
MACKAY GEOFFREYPresident & CEODec 23, 2022 Option Exercise$0.41142,01358,680387,136Dec 28, 2022, 07:18 PM
Vickers Philip J.DirectorJul 07, 2021 Buy$8.354,80040,0804,800Jul 08, 2021, 04:21 PM
Donenberg Phillip B.DirectorFeb 17, 2021 Buy$11.712,00023,4202,000Feb 18, 2021, 07:06 PM
MACKAY GEOFFREYPresident & CEODec 24, 2020 Option Exercise$0.41100,00041,320245,123Dec 28, 2020, 07:46 PM
MACKAY GEOFFREYSee RemarksFeb 12, 2020 Sale$29.071,40040,692345,123Feb 14, 2020, 07:16 PM
PAIGE CHRISTOPHERDirectorFeb 11, 2020 Sale$28.0015,000420,000252,512Feb 11, 2020, 09:26 PM
MACKAY GEOFFREYSee RemarksFeb 11, 2020 Sale$27.5763,0001,737,081364,927Feb 11, 2020, 09:23 PM
PAIGE CHRISTOPHERDirectorJan 28, 2020 Sale$23.0010,000230,000267,512Jan 30, 2020, 04:10 PM
Atlas Venture Fund X, L.P.10% OwnerJul 19, 2019 Buy$18.50810,81115,000,0045,567,289Jul 23, 2019, 04:09 PM
Booth BruceDirectorJul 19, 2019 Buy$18.50810,81115,000,0045,567,289Jul 23, 2019, 04:09 PM
PAIGE CHRISTOPHERDirectorApr 08, 2019 Sale$25.892,50064,713277,612Apr 09, 2019, 04:39 PM
PAIGE CHRISTOPHERDirectorApr 05, 2019 Sale$25.667,500192,483280,879Apr 09, 2019, 04:39 PM
MACKAY GEOFFREYSee RemarksApr 08, 2019 Sale$27.0769818,893409,523Apr 09, 2019, 04:27 PM
MACKAY GEOFFREYSee RemarksApr 05, 2019 Sale$27.2613,302362,618410,221Apr 09, 2019, 04:27 PM
Dorton KatinaChief Financial OfficerOct 08, 2018 Option Exercise$0.9110,0009,10010,000Oct 10, 2018, 06:11 PM
KREHER NERISSAChief Medical OfficerOct 08, 2018 Option Exercise$0.912,9422,6772,942Oct 10, 2018, 06:05 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Leonard Braden Michael10% Owner05/14/2024385,947
Leonard Braden Michael10% Owner05/13/2024585,546
Golipour AzadehChief Technology Officer02/05/202414,698
Ridha EssraChief Medical Officer02/05/202420,354
Ostrowski ErikInterim CEO, President and CFO02/05/202415,745
Avruch StevenChief Legal Officer02/05/202412,996
Golipour AzadehChief Technology Officer06/12/20236,635
MACKAY GEOFFREYPresident & CEO01/24/202341,859
MACKAY GEOFFREYPresident & CEO12/23/202258,680
Vickers Philip J.Director07/07/202140,080
Donenberg Phillip B.Director02/17/202123,420
MACKAY GEOFFREYPresident & CEO12/24/202041,320
MACKAY GEOFFREYSee Remarks02/12/202040,692
PAIGE CHRISTOPHERDirector02/11/2020420,000
MACKAY GEOFFREYSee Remarks02/11/20201,737,081
PAIGE CHRISTOPHERDirector01/28/2020230,000
Atlas Venture Fund X, L.P.10% Owner07/19/201915,000,004
Booth BruceDirector07/19/201915,000,004
PAIGE CHRISTOPHERDirector04/08/201964,713
PAIGE CHRISTOPHERDirector04/05/2019192,483
MACKAY GEOFFREYSee Remarks04/08/201918,893
MACKAY GEOFFREYSee Remarks04/05/2019362,618
Dorton KatinaChief Financial Officer10/08/20189,100
KREHER NERISSAChief Medical Officer10/08/20182,677
Load More Insider Transactions
FUNDS WITH A POSITION IN AVROBIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC888,1670.00179%17.03%Other
BLACKROCK INC.613,4320.00002%-0.21%Other
GEODE CAPITAL MANAGEMENT, LLC372,4390.00004%1.62%Other
GABELLI FUNDS LLC343,4210.0036%ExitedEvent Driven, Growth, Activists
CHANGE IN SHARES OUTSTANDING FOR AVROBIO INC
STOCK BUYBACKS FOR AVROBIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
1.05%
1Q
12/31/2023
06/30/2023
1.61%
2Q
12/31/2023
03/31/2023
2.17%
3Q
12/31/2023
12/31/2022
2.75%
4Q
12/31/2023
09/30/2022
2.79%
5Q
12/31/2023
06/30/2022
2.97%
6Q
12/31/2023
03/31/2022
2.97%
7Q
12/31/2023
12/31/2021
3.07%
8Q
12/31/2023
09/30/2021
3.14%
9Q
12/31/2023
06/30/2021
5.84%
10Q
12/31/2023
03/31/2021
8.11%
11Q
12/31/2023
12/31/2020
16.57%
12Q
12/31/2023
09/30/2020
23.46%
13Q
12/31/2023
06/30/2020
24.62%
14Q
12/31/2023
03/31/2020
33.64%
15Q
12/31/2023
12/31/2019
42.07%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
1.05%
1Q
06/30/2023
1.61%
2Q
03/31/2023
2.17%
3Q
12/31/2022
2.75%
4Q
09/30/2022
2.79%
5Q
06/30/2022
2.97%
6Q
03/31/2022
2.97%
7Q
12/31/2021
3.07%
8Q
09/30/2021
3.14%
9Q
06/30/2021
5.84%
10Q
03/31/2021
8.11%
11Q
12/31/2020
16.57%
12Q
09/30/2020
23.46%
13Q
06/30/2020
24.62%
14Q
03/31/2020
33.64%
15Q
12/31/2019
42.07%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AVROBIO INC
LOADING...